A study for validation of a dried blood spot based transport kit for blood cancer
- Conditions
- Health Condition 1: C959- Leukemia, unspecified
- Registration Number
- CTRI/2024/06/069601
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Untreated new acute lymphoblastic leukemia and Acute myeloid leukemia , Aged 1 month to 60 years irrespective of Gender, enrolled at study sites , diagnosed on flowcytometry using WHO criteria 2022.
2. Patients/guardians who have given informed consent given for participation in the study
3.Leukemia Patients with no history of chronic disease/MDS/ Chemotherapy/ Immunological deficient states (Routine protocol)
1. Lymphoproliferative disorder other than leukemia (Lymphoma, CMPN-AL, Secondary leukemia, MDS-AL)
2. Patients who are partially treated/referred after treatment initiation
3. Patients who are having biohazard exposures like HIV, Hbs Ag, HCV
4. Patients/guardians who are not willing to give consent for participation in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method